Histology independent drug development – Is this the future for cancer drugs?
- DOI
- 10.1016/j.ctrv.2023.102674
- Published
- 2024-02
- Container
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctrv.2023.102674,
title = {Histology independent drug development – Is this the future for cancer drugs?},
author = {Lucinda Billingham and Lynn Brown and Theodor Framke and Alastair Greystoke and Eivind Hovig and Siddhartha Mathur and Philippe Page and Elias Pean and Sahar Barjesteh van Waalwijk van Doorn-Khosrovani and Richardus Vonk and Sacha Wissink and Hilke Zander and Ruth Plummer},
year = {2024},
journal = {Cancer Treatment Reviews},
doi = {10.1016/j.ctrv.2023.102674},
url = {https://doi.org/10.1016/j.ctrv.2023.102674}
}RIS
TY - JOUR TI - Histology independent drug development – Is this the future for cancer drugs? AU - Lucinda Billingham AU - Lynn Brown AU - Theodor Framke AU - Alastair Greystoke AU - Eivind Hovig AU - Siddhartha Mathur AU - Philippe Page AU - Elias Pean AU - Sahar Barjesteh van Waalwijk van Doorn-Khosrovani AU - Richardus Vonk AU - Sacha Wissink AU - Hilke Zander AU - Ruth Plummer PY - 2024 JO - Cancer Treatment Reviews DO - 10.1016/j.ctrv.2023.102674 UR - https://doi.org/10.1016/j.ctrv.2023.102674 ER -
APA
Billingham, L., Brown, L., Framke, T., Greystoke, A., Hovig, E., Mathur, S., Page, P., Pean, E., Doorn-Khosrovani, S. B. V. W. V., Vonk, R., Wissink, S., Zander, H., & Plummer, R. (2024). Histology independent drug development – Is this the future for cancer drugs?. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2023.102674
Source records
- crossref · retrieved 2026-09-27T02:25:07.672Z